Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia. - Wikidata - awgldk - TriplyDB

Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.

Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.

http://www.wikidata.org/entity/Q53017567

about

Effect of domperidone therapy on nocturnal dyspeptic symptoms of functional dyspepsia patients.Prokinetics for the treatment of functional dyspepsia: Bayesian network meta-analysis.Saudi Gastroenterology Association position statement on safety issues associated with the use of domperidone Functional dyspepsia.The dopaminergic system in patients with functional dyspepsia analysed by single photon emission computed tomography (SPECT) and an alpha-methyl-para-tyrosine (AMPT) challenge test.Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia.Asian consensus report on functional dyspepsia.Antidepressants in the Treatment of Functional Dyspepsia: A Systematic Review and Meta-Analysis.Current and emerging therapies for the management of functional gastrointestinal disorders.Acupuncture for patients with functional dyspepsia: study protocol of a randomised controlled trial Irregular gastrointestinal drug absorption in Parkinson's disease.Concomitant gastroparesis negatively affects children with functional gallbladder disease.Strategy for treatment of nonerosive reflux disease in Asia Effects of Lizhong Tang on gastrointestinal motility in mice.Nonmotor gastrointestinal disorders in older patients with Parkinson's disease: is there hope?Itopride for gastric volume, gastric emptying and drinking capacity in functional dyspepsia.Gastrointestinal dysfunction in idiopathic Parkinsonism: A narrative review.Acupuncture for functional dyspepsia: study protocol for a two-center, randomized controlled trial.Women and functional dyspepsia Epidemiology, approach and management of functional dyspepsia in Thailand.Why dyspepsia can occur without organic disease: pathogenesis and management of functional dyspepsia.An update on current pharmacotherapy options for dyspepsia.Evidence-based approach to dyspepsia: from Helicobacter pylori to functional disease.A review of drug therapy for functional dyspepsia.Visceral hypersensitivity and electromechanical dysfunction as therapeutic targets in pediatric functional dyspepsia.Emerging drugs for functional dyspepsia.Newest Drugs for Chronic Unexplained Nausea and Vomiting.Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups?Randomised clinical trial: an assessment of acupuncture on specific meridian or specific acupoint vs. sham acupuncture for treating functional dyspepsia.The effect of levosulpiride on in vitro motor patterns in the human gastric fundus, antrum, and jejunum.Prokinetic effect of a standardized yarrow (Achillea millefolium) extract and its constituent choline: studies in the mouse and human stomach.Mosapride treatment for functional dyspepsia: a meta-analysis.Meranzin Hydrate Induces Similar Effect to Fructus Aurantii on Intestinal Motility through Activation of H1 Histamine Receptors Asian consensus report on functional dyspepsia Itopride in the Treatment of Functional Dyspepsia in Chinese Patients Gastroprotective and gastric motility benefits of AD-lico/Healthy Gut™ Glycyrrhiza inflata extract

P2860

Q33629448-0913E937-6D33-4FCD-8D1D-B3DE150CDA66 Q33836928-06234625-4C7A-413B-B88F-602DCC6B5CAF Q34335273-AE83FAF6-1D14-4EC5-86B9-C08F8C02732E Q34409166-394D1BB5-F5FF-4303-970B-CBC23B975E11 Q35861384-37383B16-4341-4EA0-B691-832178C9D0AB Q35872064-51BAAEA0-F0C9-4F72-8AB0-49A092CD6A06 Q35885912-CB4C7597-22AD-46B3-BE55-DE1632E95DC1 Q36054184-A11E2743-3AC2-47A0-B0C0-433C628E3E04 Q36443725-48D9548C-CD0C-44C3-ABBF-41D88DD15FBA Q37065016-3CC863D5-D2D6-499D-ABD1-F804CAD49BEE Q37076343-85BA645E-ED18-4BF5-9D88-937CD0AF9864 Q37090005-FEA38DDF-3CF0-4695-9706-8E9C13F7EF6C Q37174645-9E9FD736-0E14-45ED-AF0B-A918707C1794 Q37242785-B9B4C3CD-CD17-45C3-B04D-835E375DD286 Q37420777-FC4AFE60-892A-42DD-BE6D-497A00814B0E Q37625529-ADF39963-57A6-410A-895F-BAEE9DB7735E Q37697903-B915553C-76EE-4DAB-B755-9AD43B508D90 Q37714702-C0474EF6-E7EF-4265-8817-ACDFECAC8C4C Q37732178-F5C104A6-00C9-4E73-8AA4-EA965956AE85 Q37858637-F01403E7-EC40-4EBF-86B1-41E7A4519FC6 Q38024259-B8C1D484-F672-4F60-A09A-BBA3C64F7B78 Q38115358-D0487B6B-CBAE-4417-86EC-037E5D07CDAA Q38128176-291DCD05-4D2B-488B-B1C3-C5FC7C9C50DD Q38129952-8189AF73-855D-4366-91D1-34EEB574E5E9 Q38240885-47F2B4FD-98B1-4EB6-AA14-1B27A7B48EF9 Q38342083-7C282041-3E49-472B-ADF8-0948D46F5F47 Q38977503-CF63C431-2057-432B-B9D8-F6ED3A6915A8 Q39278329-55FA392F-CF5A-4C40-A965-4216EFE22730 Q47233856-9DA83725-C858-4144-9F98-B54D8995E268 Q50263190-DA098E95-4C4A-4918-B8AE-66085AA603CB Q50521102-8B5DD8BF-46C1-4CFC-9FAD-F27AD8B4A608 Q53149792-6AF0DED2-FDA8-4079-9644-A38BBB00E3B8 Q57500278-4B375348-F46D-4DDA-9973-E84C1F9270BE Q57728314-494E4357-592E-4F39-BA93-79B5DF27954C Q57789406-9C277573-0A02-4C22-87EC-87BCFAB7488A Q58257238-A7E827C6-0C25-4374-98AE-5B80037042A6

P2860

Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.

http://www.wikidata.org/entity/Q53017567

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.

@en

Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.

@nl

type

label

Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.

@en

Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.

@nl

prefLabel

Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.

@en

Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.

@nl

P1433

Q53017567-1238D482-5429-44E1-9924-ABDCAC3CD20E

P1476

Q53017567-A9FF36EE-CC31-462B-9230-A47C8BE03725

P2093

Q53017567-11CCC9AE-1545-4DA6-88B2-A402F8351353

Q53017567-38E3F040-3AF6-4BD4-B14A-689F72C90504

Q53017567-420BB329-8518-4F92-9BBE-BC29C1FE0EA5

Q53017567-4CCD8811-05C3-43A0-BE41-8CA6D1B6ADDA

Q53017567-B099C8B4-BDD0-411B-A4B4-7E7057221DA5

Q53017567-D362A130-6178-41F5-98A0-E4B6353B7373

Q53017567-D8F97526-EE42-4B31-A5B8-CF2B3C462139

Q53017567-DD295527-3BAE-4F9F-84FD-7D03890CBAD3

Q53017567-F817829D-B973-4901-A0BA-1E4D94199C3D

P2860

Q53017567-02207B7E-EF4A-4133-9A72-F5706BBDE997

Q53017567-078DD8E3-D159-4676-99CF-A03FEDA046DB

Q53017567-2B0386D6-F230-4856-86A9-BC6F7428A154

Q53017567-2C991331-C3F8-4C44-950B-FBD29C91AD0D

Q53017567-2DBF37C2-F46D-4FDC-98DB-2B57DA05763C

Q53017567-53A9B018-6ECA-45A6-92E6-69185FD16423

Q53017567-669C6DDB-40D1-4D3F-930E-5409A318BC56

Q53017567-67455EAD-52C8-41D1-B057-F0999C3A9489

Q53017567-6AF2BABC-A230-4B32-A54A-D42C5FFC29DF

Q53017567-6F9C7076-1645-4017-9318-4466209766E9

P304

Q53017567-F24068E2-9108-4909-BC2A-92B8CA828FF0

P31

Q53017567-ABB33B73-8B48-471B-8984-1077AC1B4852

Q53017567-df11ffdb-225a-4faa-8d38-8e102cc42ffe

P356

Q53017567-E296D9CA-A119-4BBA-A631-14A3FD655221

P433

Q53017567-B3CDFB36-FF3B-4792-8EE8-44B29C557486

P478

Q53017567-EB957AE1-2C09-468C-B704-A26DDCC8B96C

P50

Q53017567-04A63CE4-AFF3-430A-A263-E5B87FB7838E

P577

Q53017567-3B8D06BC-25EB-4CFD-8086-92E49158E89F

P698

Q53017567-506F317F-CB21-4488-B2B4-D4ED0B7B0AD6

P921

Q53017567-8F6459BA-71AF-4ACB-9863-91249393A3FC

Q53017567-E3F142A1-7CA9-4247-8588-5A3BA9660AE5

P356

J.1440-1746.2006.04493.X

P1433

Journal of Gastroenterology and Hepatology

P1476

Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.

@en

P2093

Hiroaki Kusunoki

http://www.w3.org/2001/XMLSchema#string

Kazuaki Chayama

http://www.w3.org/2001/XMLSchema#string

Ken Haruma

http://www.w3.org/2001/XMLSchema#string

Masaharu Yoshihara

http://www.w3.org/2001/XMLSchema#string

Masanori Ito

http://www.w3.org/2001/XMLSchema#string

Nobuo Nishi

http://www.w3.org/2001/XMLSchema#string

Shinji Tanaka

http://www.w3.org/2001/XMLSchema#string

Tomoari Kamada

http://www.w3.org/2001/XMLSchema#string

Toru Hiyama

http://www.w3.org/2001/XMLSchema#string

P2860

Operating characteristics of a rank correlation test for publication bias

Meta-analysis in clinical trials

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.

Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer.

New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline.

Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics.

Systematic review: the methodological quality of trials affects estimates of treatment efficacy in functional (non-ulcer) dyspepsia.

Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies.

Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia.

P304

304-310

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1440-1746.2006.04493.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17295758

http://www.w3.org/2001/XMLSchema#string

P921